Trial intelligence / Profile preview

Raltegravir Intensification in HIV-1 Patients on HAART

NCT00807443Phase 2Completed

Start
Sep 2009
Primary completion
Dec 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of raltegravir in human immunodeficiency virus type 1 infection (HIV-1). Started Sep 2009; status: completed.

02

Drugs

raltegravir
03

Conditions

human immunodeficiency virus type 1 infection (HIV-1)

Beyond the preview

Go deeper on NCT00807443.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00807443.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call